Healthcare costs of inflammatory myopathies

Journal of Rheumatology

Volumn 38, Issue 5, 2011, Pages 885-888

  Bernatsky, Sasha ^a   Panopalis, Pantelis ^a   Pineau, Christian A ^a   Hudson, Marie ^b   St Pierre, Yvan ^a   Clarke, Ann E ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Dermatomyositis; Epidemiology; Health services research; Polymyositis

Indexed keywords

ADULT; AGE; ARTICLE; CANADA; DERMATOMYOSITIS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; MALE; MEDICAL FEE; MYOSITIS; POLYMYOSITIS; PREDICTION; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; COHORT STUDIES; DERMATOMYOSITIS; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; MALE; MIDDLE AGED; MYOSITIS; POLYMYOSITIS; PREVALENCE; QUEBEC; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 79955569592     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101083     Document Type: Article

References (17)

1. Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006;25:234-9. (Pubitemid 43372323)
2. Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM, et al; IMACS Group. Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum 2009;60:3425-35.
3. Tisseverasinghe A, Bernatsky S, Pineau CA. Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 2009;36:1943-6.
4. Bernatsky S, Joseph L, Pineau CA, Bélisle P, Boivin JF, Banerjee D, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2009;68:1192-6.
5. Bernatsky S, Linenham T, Hanly JG. The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011 [in press].
6. La Régie de l'assurance maladie du Québec Tarif des actes médicaux, Quebec. Quebec City: RAMQ; 2003. [Internet. Accessed February 14, 2011.] Available from: http://www.ramq.gouv.qc.ca/fr/ professionnels/medspe/ manuel/manu-tdm.shtml
7. Ontario guide to case-costing. Ontario Case-Costing Initiative, Ministry of Health and Long-Term Care, Health Data Branch, Data Standards Unit, Toronto, 2010. [Internet. Accessed January 13, 2011.] Available from: http://www.occp.com
8. Bank of Canada. Rates and statistics inflation calculator. [Internet. Accessed January 13, 2011.] Available from: http://www.bankofcanada.ca/en/rates/ inflation-calc.html
9. Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A, for the German Collaborative Arthritis Centres. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis 2006;65:1175-83.
10. Clarke AE, Zowall H, Levinton C, Assimakopoulos H, Sibley JT, Haga M, et al. Direct and indirect medical services costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol 1997;24:1051-60. (Pubitemid 27250108)
11. Callaghan R, Prabu A, Allan RB, Clarke AE, Sutcliffe N, St. Pierre Y, et al. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome. Rheumatology 2007;46:105-11. (Pubitemid 44932796)
12. Bernatsky S, Dobkin PL, De Civita M, Penrod JR. Co-morbidity and physician use in fibromyalgia. Swiss Med Wkly 2005; 135:76-81.
13. Lacaille D, Clarke AE, Bloch DA, Danoff D, Esdaile JM. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. J Rheumatol 1994;21:448-53. (Pubitemid 24102828)
14. Bernatsky S, Duffy C, Malleson P, Feldman DE, St. Pierre Y, Clarke AE. Economic impact of juvenile idiopathic arthritis. Arthritis Rheum 2007;57:44-8.
15. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senecal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine 2005;84:231-49. (Pubitemid 41026298)
16. Klein R, Teal V, Taylor L, Troxel A, Werth V. Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol 2007;57:937-43. (Pubitemid 350087354)
17. Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, Leclercq S, et al; Canadian Scleroderma Research Group. The cost of systemic sclerosis. Arthritis Rheum 2009;61:119-23.